Article Details

Eidos Therapeutics, Inc. (NASDAQ:EIDX) Given Average Rating of "Hold" by Brokerages

Retrieved on: 2020-12-16 06:56:15

Tags for this article:

Click the tags to see associated articles and topics

Eidos Therapeutics, Inc. (NASDAQ:EIDX) Given Average Rating of "Hold" by Brokerages. View article details on hiswai:

Excerpt

<b>Vanguard Group</b> Inc. now owns 695,252 shares of the company's stock worth $33,142,000 after purchasing an additional 251,429 shares during the ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up